Brain regional alterations in the modulation of the glutamate-nitric oxide-cGMP pathway in liver cirrhosis. Role of hyperammonemia and cell types involved

Neurochemistry International

Volumn 48, Issue 6-7, 2006, Pages 472-477

  Rodrigo, Regina ^a   Felipo, Vicente ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

cGMP; Glutamate; Hyperammonemia; Liver failure; Nitric oxide

Indexed keywords

AMMONIA; CYCLIC GMP; GLUTAMIC ACID; GUANYLATE CYCLASE; NITRIC OXIDE;

ARTICLE; ASTROCYTE; BILE DUCT LIGATION; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; CAUSE OF DEATH; CELL ACTIVITY; CELL TYPE; CEREBELLUM; COORDINATION; ENZYME ACTIVATION; ENZYME REGULATION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; IN VIVO STUDY; INTELLECT; LIVER CIRRHOSIS; LIVER FAILURE; NERVE CELL; NEUROMUSCULAR FUNCTION; NEUROPSYCHIATRY; NEUROTRANSMISSION; NONHUMAN; PERSONALITY DISORDER; PORTOCAVAL SHUNT; PRIORITY JOURNAL; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TISSUE CULTURE;

ANIMALS; ASTROCYTES; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CHRONIC DISEASE; CYCLIC GMP; GLUTAMIC ACID; GUANYLATE CYCLASE; HUMANS; HYPERAMMONEMIA; LIVER CIRRHOSIS; LIVER FAILURE; NEURONS; NITRIC OXIDE; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 33645863470     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.10.014     Document Type: Article

References (20)

1. Azorin I., Miñana M.D., Felipo V., and Grisolia S. A simple animal model of hyperammonemia. Hepatology 10 (1989) 311-314
2. Boulton C.L., Southam E., and Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69 (1995) 699-703
3. Butterworth R.F. Evidence that hepatic encephalopathy results from a defect of glutamatergic synaptic regulation. Mol. Neuropharmacol. 2 (1992) 229-232
4. Corbalán R., Chatauret N., Behrends S., Butterworth R.F., and Felipo V. Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients. Hepatology 36 (2002) 1155-1162
5. Felipo V., and Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 67 (2002) 259-279
6. Gasull T., DeGregorio-Rocasolano N., Zapata A., and Trullas R. Choline release and inhibition of phosphatidylcholine synthesis precede excitotoxic neuronal death but not neurotoxicity induced by serum deprivation. J. Biol. Chem. 275 24 (2000) 18350-18357
7. Hawkins R.D. No honey, I don't remember. Neuron 16 (1996) 465-467
8. Hayashi T., Katsumi Y., Mukai T., Inoue M., Nagahama Y., Oyanagi C., Yamauchi H., Shibasaki H., and Fukuyama H. Neuronal nitric oxide has a role as a perfusion regulator and a synaptic modulator in cerebellum but not in neocortex during somatosensory stimulation-an animal PET study. Neurosci. Res. 44 2 (2002) 155-165
9. Hermenegildo C., Montoliu C., Llansola M., Muñoz M.D., Gaztelu J.M., Miñana M.D., and Felipo V. Chronic hyperammonemia impairs glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur. J. Neurosci. 10 (1998) 3201-3209
10. Lombardi G., Mannaioni P., Leonardi P., Cherici G., Carlà V., and Moroni F. Ammonium acetate inhibits ionotropic receptors and differentially affects metabotropic receptors for glutamate. J. Neural. Transm. Gen. Sect. 97 (1994) 187-196
11. Marcaida G., Miñana M.D., Burgal M., Grisolía S., and Felipo V. Ammonia prevents activation of NMDA receptors in rat cerebellar neuonal cultures. J. Neurosci. 7 (1995) 2389-2396
12. Michalak A., Knecht K., and Butterworth R.F. Hepatic encephalopathy in acute liver failure: role of the glutamate system. Adv. Exp. Med. Biol. 420 (1997) 35-44
13. Miñana M.D., Llansola C., Hermenegildo C., Cucarella C., Montoliu C., Grisolía S., and Felipo V. Glutamate and muscarinic receptors in the molecular mechanisms of acute ammonia toxicity and of its prevention. Adv. Exp. Med. Biol. 420 (1997) 45-56
14. Monfort P., Corbalán R., Martínez L., López-Talavera J.C., Córdoba J., and Felipo V. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis. Neuroscience 104 (2001) 1127-1139
15. Monfort P., Muñoz M.D., ElAyadi A., Kosenko E., and Felipo V. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab. Brain Dis. 17 4 (2002) 237-250
16. Moroni F., Lombardi G., Moneti G., and Cortesini C. The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J. Neurochem. 40 (1983) 850-854
17. Paolillo M., Feliciello A., Porcellini A., Garbi C., Bifulco M., Schinelli S., Ventra C., Stabile E., Ricciardelli G., Schettini G., and Avvedimento E.V. The type and the localization of cAMP-dependent protein kinase regulate transmission of cAMP signals to the nucleus in cortical and cerebellar granule cells. J. Biol. Chem. 274 10 (1999) 6546-6552
18. Rao V.L.R., and Murthy C.R.K. Hyperammonemic alterations in the uptake and release of glutamate and aspartate by rat cerebellar preparations. Neurosci. Lett. 130 (1991) 49-52
19. Rodrigo R., Jover R., Candela A., Compañ A., Sáez-Valero J., Erceg S., and Felipo V. Bile Duch ligation plus hyperammonemia in rats reproduces the alterations in the modulation of soluble guanylate cyclase by nitric oxide in brain of cirrhotic patients. Neuroscience 130 (2005) 435-443
20. Rodrigo R., Erceg S., and Felipo V. Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in the cerebellum and cortex in patients with liver cirrhosis. Neurobiol. Dis. 19 (2005) 150-161